Clinical Trial Update: Melatonin Treatment for Tardive Dyskinesia in Schizophrenia [NA]

View source ↗

Summary

This completed clinical trial evaluated melatonin as a treatment for tardive dyskinesia in individuals with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tardive Dyskinesia

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Beijing HuiLongGuan Hospital | Conditions: Tardive Dyskinesia | NA | Status: COMPLETED